GlassScriptPhysician profile
Serv S Wahan
NPI 1376564229
$5,929.70
in general payments reported to CMS, 2019-2025
8 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $392 · 2021: $2,484 · 2022: $934 · 2023: $862 · 2024: $294 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $41.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $41.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,181.03 | 2019-2025 | |
| Nobel Biocare USA | $2,276.90 | 2019-2023 | Nobelactive |
| Zimvie INC. | $297.05 | 2023-2025 | |
| Dentsply Sirona INC | $78.09 | 2019-2024 | Astra Tech Implant System |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $35.96 | 2023 | |
| Kls-Martin L.P. | $30.82 | 2024 | |
| Geistlich Pharma, North America, INC. | $16.72 | 2020 | |
| Zimmer Biomet Holdings, INC. | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Serv Wahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.